HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 493-504 of 4,505
Drug study icon
CompletedNCT00212784

Asenapine Using an Active Control for schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of olanzapine for people with schizophrenia.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Organon and Co
Drug study icon
CompletedNCT00212771

Asenapine Using an Active Control for schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of asenapine for people with schizophrenia.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Organon and Co
Drug study icon
CompletedNCT00512070

Melatonin Metabolism Abnormality in people with Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Official study title

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality

This study has finished and is no longer accepting participants.

In Tacoma
Schizophrenia, BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Seattle Institute for Biomedical and Clinical Research
Drug study icon
CompletedNCT06319170

Study Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in people with Schizophrenia/Schizoaffective Disorder

Official study title

A Multi-center, Open-label, Randomized, Parallel-group Trial to Characterize the Pharmacokinetics of Three SC Olanzapine Extended-release Formulations With Different Release Rates Following Single Administration in Participants With Schizophrenia or Schizoaffective Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Los Alamitos
SchizophreniaMedication studyAges 18–64
Countries
United States
Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Drug study icon
CompletedNCT01490086

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

What is this study about?

This study evaluated the safety and effectiveness of RP5063 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Philadelphia
SchizophreniaMedication studyAges 18–65
Countries
United States, India, Malaysia, + 2 others
Sponsor
Reviva Pharmaceuticals
Behavioral study icon
RecruitingNCT05157620

Yoga or wellness activities for veterans with serious mental health conditions

About this title

Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness

Read the official source — NCT05157620
Official study title

Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness

In Pittsburgh
Schizophrenia, BipolarityInterventional studyAges 18–70
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Other study type icon
RecruitingISRCTN71800376

Sleeping Better

In United Kingdom
SchizophreniaResearch studyAges 14+
Countries
United Kingdom
Sponsor
University of Oxford (University)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.